BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38193678)

  • 21. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using
    Nodoushani A; El-Sady MS; Park MA; Castilloveitia GL; Falk RH; Di Carli MF; Kijewski MF; Dorbala S
    J Nucl Cardiol; 2021 Oct; 28(5):2004-2010. PubMed ID: 31758410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
    Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18 F-Florbetapir PET/CT and 68 Ga-FAPI PET/CT in a Case of Light Chain Amyloidosis With Predominant Multiple Tumor-Like Deposits.
    Zhang Y; Wang X; Ren C; Shen K; Huo L
    Clin Nucl Med; 2024 May; 49(5):486-488. PubMed ID: 38465960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis.
    Ghio S; Perlini S; Palladini G; Marsan NA; Faggiano G; Vezzoli M; Klersy C; Campana C; Merlini G; Tavazzi L
    Eur J Heart Fail; 2007 Aug; 9(8):808-13. PubMed ID: 17586091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
    Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis.
    Cappelli F; Baldasseroni S; Bergesio F; Padeletti L; Attanà P; Pignone AM; Grifoni E; Ciuti G; Fabbri A; Tarantini F; Marchionni N; Gensini GF; Perfetto F
    Amyloid; 2014 Jun; 21(2):97-102. PubMed ID: 24517408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of florbetapir-PET for imaging beta-amyloid pathology.
    Clark CM; Schneider JA; Bedell BJ; Beach TG; Bilker WB; Mintun MA; Pontecorvo MJ; Hefti F; Carpenter AP; Flitter ML; Krautkramer MJ; Kung HF; Coleman RE; Doraiswamy PM; Fleisher AS; Sabbagh MN; Sadowsky CH; Reiman EP; Zehntner SP; Skovronsky DM;
    JAMA; 2011 Jan; 305(3):275-83. PubMed ID: 21245183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four chamber right ventricular longitudinal strain versus right free wall longitudinal strain. Prognostic value in patients with left heart disease.
    García-Martín A; Moya-Mur JL; Carbonell-San Román SA; García-Lledó A; Navas-Tejedor P; Muriel A; Rodríguez-Muñoz D; Casas-Rojo E; Jiménez-Nacher JJ; Fernández-Golfín C; Zamorano JL
    Cardiol J; 2016; 23(2):189-94. PubMed ID: 26711464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of right ventricular three-dimensional speckle-tracking strain in adult heart transplantation patients.
    Li M; Lv Q; Sun W; Zhang Y; Wu C; Zhang Y; Zhu S; Li H; Dong N; Li Y; Zhang L; Xie M
    Int J Cardiovasc Imaging; 2023 Jul; 39(7):1275-1287. PubMed ID: 37027106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Accuracy of [
    Rosengren S; Skibsted Clemmensen T; Tolbod L; Granstam SO; Eiskjær H; Wikström G; Vedin O; Kero T; Lubberink M; Harms HJ; Flachskampf FA; Baron T; Carlson K; Mikkelsen F; Antoni G; Frost Andersen N; Hvitfeldt Poulsen S; Sörensen J
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1337-1347. PubMed ID: 32417330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Amyloidosis Detected Using
    García-González P; Cozar-Santiago MDP; Maceira AM
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1215. PubMed ID: 27178118
    [No Abstract]   [Full Text] [Related]  

  • 32. Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy.
    Vitarelli A; Lai S; Petrucci MT; Gaudio C; Capotosto L; Mangieri E; Ricci S; Germanò G; De Sio S; Truscelli G; Vozella F; Pergolini MS; Giordano M
    Int J Cardiol; 2018 Nov; 271():371-377. PubMed ID: 30049493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel imaging techniques using
    Shouman K; Broski SM; Muchtar E; Pendleton CA; Johnson GB; Tracy J; Engelstad JK; Spinner RJ; Dyck PJB
    Muscle Nerve; 2021 Jan; 63(1):104-108. PubMed ID: 33094511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-Florbetapir PET in Primary Cerebral Amyloidoma.
    Soffers F; Ceyssens S; Buffet W; de Surgeloose D; Crols R
    Clin Nucl Med; 2020 Oct; 45(10):838-839. PubMed ID: 32796236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
    Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
    JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
    Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
    J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
    Banypersad SM; Sado DM; Flett AS; Gibbs SD; Pinney JH; Maestrini V; Cox AT; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2013 Jan; 6(1):34-9. PubMed ID: 23192846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.